Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-19-020686

EVP, CFO & CBO acquired 15,486 shares (option exercise)

  • EVP, CFO & CBO gave up 2,625 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Mahatme Sandesh · EVP, CFO & CBO

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2019-03-19 Exercise or conversion : show line 1 in the form +11,768 $23.85 $280,667 15,636 D
2019-03-19 Exercise or conversion : show line 2 in the form +3,511 $13.90 $48,803 19,147 D
2019-03-19 Exercise or conversion : show line 3 in the form +164 $13.71 $2,248 19,311 D
2019-03-19 Exercise or conversion : show line 4 in the form +43 $13.71 $590 19,354 D
2019-03-19 Shares withheld for taxes : show line 5 in the form −2,625 $126.47 $331,984 16,729 D

Table II: Derivative

4 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-03-19 Exercise or conversion : show line 6 in the form Stock option (right to buy) −11,768 $23.85 2022-11-05 11,768 0 D
2019-03-19 Exercise or conversion : show line 7 in the form Stock option (right to buy) −3,511 $13.90 2025-02-27 3,511 2,625 D
2019-03-19 Exercise or conversion : show line 8 in the form Stock option (right to buy) −164 $13.71 2026-02-28 164 3,370 D
2019-03-19 Exercise or conversion : show line 9 in the form Stock option (right to buy) −43 $13.71 2026-02-28 43 478 D
Loading xslF345X03/doc4.xml…